Project Grant SB1AR086711
- The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant of $413,655 on August 1, 2025 to Arizona State University (ASU) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant will fund research to develop biomaterials with temporal control of proteins, such as Bone Morphogenetic Proteins (BMPs), to enhance bone repair. The research aims to mimic natural extracellular matrix interactions and synergies...
- This $430,152 Project Grant was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports the development of a stand-alone simulation platform for designing tissue engineering scaffolds to serve as bone graft substitutes. The platform will leverage COMSOL software and JMP statistical design functionality to optimize the architecture and composition of...
- This federal Project Grant award of $306,722 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funding supports Penderia Technologies Inc., a small business joint venture located in Eugene, Oregon, to fabricate and characterize a distal femoral fracture fixation plate that features an implantable, battery-free, wireless sensor. This sensor will enable...
- This $219,609 project grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) is aimed at developing a method to assess mechanical failure of bone matrix using in vitro cell culture. The primary goal is to overcome the current challenge of requiring whole mouse bone specimens to detect changes in bone matrix mechanical properties, by using micropillars generated from...
- The University of Pittsburgh received a $158,555 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846). The grant is for the development and evaluation of a personalized, wireless, electronic-free metamaterial interbody fusion cage that can precisely measure forces during spinal fusion in-vivo and transmit the data wirelessly in real-time. The project...
- This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $314,362 to Reselute, Inc. to develop the ReselutionTM Hindfoot Intramedullary Nail. The goal of this project is to create a combination implant that integrates structural support with sustained local antibiotic delivery to prevent infections while stabilizing fractures and fusions in...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $616,256 Project Grant to Cleveland State University for the development and pre-clinical validation of an "intelligent biorobot" to aid in the regenerative rehabilitation of volumetric muscle loss (VML) injuries. The goal of the project is to create a piezoelectric construct that can deliver electrical stimulation to facilitate the formation of innervated, vascularized, and functional muscle...
- This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $830,712 to Peer Technologies PLLC to commercialize a novel lumbar interbody fusion technology. The project, titled "SMART CAVITY CREATOR DRILL FOR LUMBAR INTERBODY FUSION: DIRECT TO PHASE II," aims to develop a sensor-enabled, articulated drill bit ("Smart Cavity...
- This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is developing the X-Visual, a sensor to track fracture healing in cannulated screws used for hip fracture fixation. The $299,999 award to Aravis Biotech LLC will cover the design, computational modeling, and initial testing of this innovative device that can non-invasively measure screw bending...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $2,070,827 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846) to the Icahn School of Medicine at Mount Sinai. This grant aims to identify novel microbial factors that can enhance wound repair, a significant public health issue with over 100 million new acute skin wounds annually and substantial treatment costs exceeding $25 billion. The...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $594,000 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Poly Orth International to develop a 3D-printed "Skin and Bone Integrated Pylon" (SBIP) for direct skeletal attachment of limb prostheses. The research aims to demonstrate the feasibility and safety of this novel prosthetic technology, which can potentially benefit patients who cannot use traditional socket-based prostheses. The project will include large animal studies over a 30-month period to meet FDA requirements for translating the technology to human trials. The 3D-printed SBIP is designed to integrate with the patient's residual bone and skin, minimizing the risk of infection and secondary trauma compared to conventional prosthetic attachment methods.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $594.0k | 9/2/25 |